CareRx Announces Q4 2026 Dividend

(TSX:CRRX) CareRx Corporation announced that its Board of Directors has declared a dividend of CAD$0.022 per outstanding common share. The dividend will be payable on January 7, 2027. The record date for shareholders entitled to receive the dividend is the close of business on December 14, 2026. This dividend is designated as an 'eligible dividend' for Canadian income tax purposes. Dividends paid or credited to non-residents of Canada are subject to withholding tax, which may be reduced by treaty. The taxation of dividends paid to U.S. residents is governed by the Internal Revenue Code. The company advises shareholders to consult a tax advisor to determine any tax consequences of receiving dividends from CareRx. CareRx Corporation is described as Canada's leading provider of pharmacy services to seniors living and other congregate care communities. The company operates a national network of pharmacy fulfillment centers across the country. CareRx uses technology to automate the preparation and verification of multi-dose compliance packaging of medication. The company works with home operator partners to promote resident health, staff education, and medication system quality and efficiency.

CareRx Reports Results for the Third Quarter of 2026

(TSX:CRRX) CareRx Corporation reported its financial results for the third quarter ended September 30, 2026. Average Beds Serviced increased to 93,225 in Q3 2026 from 91,298 in Q3 2025 and 91,719 in Q2 2026. Revenue rose to $95.3 million in Q3 2026, compared to $93.2 million in Q3 2025 and $93.6 million in Q2 2026. Adjusted EBITDA decreased to $8.1 million in Q3 2026 from $8.3 million in Q3 2025 and $8.0 million in Q2 2026. Adjusted EBITDA Margin declined to 8.5% in Q3 2026 from 9.0% in Q3 2025 and 8.6% in Q2 2026. Cash from Operations decreased to $6.5 million in Q3 2026, compared to $10.1 million in Q3 2025 and $3.7 million in Q2 2026. The company onboarded approximately 3,000 new retirement residents in Q3 2026, pursuant to a previously announced long-term contract with a national seniors home operator. On September 15, 2026, the TSX approved the renewal of CareRx's normal course issuer bid (NCIB), allowing repurchase for cancellation of up to 1,750,000 common shares from September 17, 2026, to September 16, 2027. Between September 1 and October 31, 2026, CareRx repurchased approximately 258,000 common shares for an aggregate value of approximately $830,000. On August 27, 2026, CareRx closed a new credit agreement with National Bank of Canada, replacing its existing credit facility. The new credit agreement is expected to provide greater financial flexibility, dedicated capacity to invest in the business, and reduce the overall cost of capital. CareRx will relocate its corporate and registered office from Toronto to Richmond Hill in early 2027, with offices operating adjacent to its Richmond Hill, Ontario fulfilment centre. After Q3, CareRx closed one pharmacy location in Western Canada and relocated the beds serviced by this pharmacy to another fulfilment centre. The Board of Directors declared a quarterly dividend of $0.022 per common share, payable on January 7, 2027, to shareholders of record as of December 14, 2026. For Q3 2026, revenue was $95,280,000, EBITDA was $7,221,000, Adjusted EBITDA was $8,064,000, Adjusted EBITDA per share (basic) was $0.13, Adjusted EBITDA Margin was 8.5%, net income was $241,000, and cash provided by operations was $6,461,000. For the nine months ended September 30, 2026, revenue was $282,774,000, EBITDA was $21,487,000, Adjusted EBITDA was $24,505,000, Adjusted EBITDA per share (basic) was $0.39, Adjusted EBITDA Margin was 8.7%, net income was $1,773,000, and cash provided by operations was $17,079,000. Total assets as of September 30, 2026, were $243,623,000 and total liabilities were $135,192,000. Net Debt increased to $29.6 million in Q3 2026 from $28.8 million in Q3 2025, due to a decrease in cash and cash equivalents ($10.7 million in Q3 2026 vs $15.5 million in Q3 2025), despite a reduction in borrowings ($40.3 million in Q3 2026 vs $44.3 million in Q3 2025). The Q4 2026 dividend is designated as an "eligible dividend" for Canadian income tax purposes. The company will host a conference call on November 5, 2026, at 8:30 a.m. ET to discuss these results.

CareRx Announces New Credit Agreement with National Bank of Canada

(TSX: CRRX) CareRx Corporation announced that it has entered into and closed a new credit agreement with National Bank of Canada. The New Credit Agreement includes up to a $20 million senior secured revolving operating facility, up to a $40 million senior secured term loan, and up to a $10 million senior secured facility dedicated to acquisitions and capital expenditures. At closing, the Company completed a draw of $40 million under the Term Loan, with no amounts drawn under the Revolver or the Acquisition and Capex Facility. The proceeds of this draw will be used to repay and discharge the outstanding amounts under the Company's existing credit facility. Subject to the terms of the New Credit Agreement, CareRx can increase the principal amount of the Revolver as well as the Acquisition and Capex Facility by up to an aggregate of $20 million. The Credit Facilities are secured by substantially all of the assets of the Company and its subsidiaries, and are subject to customary financial and non-financial covenants, including restrictions on incurring additional debt, distributions, and acquisitions. The Company will realize cost savings under the New Credit Agreement relative to its existing facility.

CareRx Reports Results for the Second Quarter of 2026

(TSX: CRRX) CareRx Corporation reported its financial results for the second quarter ended June 30, 2026, with revenue increasing to $93,571,000 in Q2 2026 compared to $91,390,000 in Q2 2025. Average Beds Serviced increased to 91,719 in Q2 2026 from 90,048 in Q2 2025, and Adjusted EBITDA remained consistent at $8,024,000 in Q2 2026 versus $7,997,000 in Q2 2025. Adjusted EBITDA Margin decreased to 8.6% in Q2 2026 from 8.8% in Q2 2025. Cash provided by operations was $3,692,000 in Q2 2026, compared to $3,769,000 in Q2 2025. The Company entered into a long-term contract with a national seniors home operator, expecting to service an additional estimated 3,000 new retirement residents, with onboarding commencing in the third quarter of 2026. The Board of Directors declared a quarterly dividend of CAD$0.022 per common share, a 10% increase over the previous quarterly dividend.

CareRx Announces Q3 2026 Dividend

(TSX: CRRX) CareRx Corporation announced that its Board of Directors has declared a dividend of CAD$0.022 per outstanding common share of the Company, payable on October 8, 2026, to holders of record as of the close of business on September 15, 2026. The dividend is designated as an "eligible dividend" for Canadian income tax purposes. Dividends paid or credited to non-residents of Canada are subject to withholding tax, which may be reduced by treaty. Taxation of dividends paid to U.S. residents is governed by the Internal Revenue Code. CareRx is described as Canada's leading provider of pharmacy services to seniors living and other congregate care communities. The company operates a large network of pharmacy fulfillment centers strategically located across the country. The company uses best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication.

CareRx Announces Q2 2026 Dividend

CareRx Corporation (TSX: CRRX) announced that its Board of Directors has declared a dividend of CAD$0.02 per outstanding common share. The dividend will be payable on July 9, 2026, to shareholders of record as of June 23, 2026. The dividend is designated as an 'eligible dividend' for Canadian income tax purposes. Dividends paid to non-residents of Canada are subject to withholding tax, and U.S. residents are subject to the Internal Revenue Code. CareRx is described as Canada's leading provider of pharmacy services to seniors living and other congregate care communities.

CareRx Reports Results for The First Quarter of 2026

CareRx Corporation (TSX: CRRX) reported its financial results for the first quarter ended March 31, 2026. Revenue increased to $93.9 million in Q1 2026 from $89.6 million in Q1 2025, and Adjusted EBITDA rose to $8.4 million from $7.8 million year-over-year. Average Beds Serviced grew to 92,036 in Q1 2026, up from 87,675 in Q1 2025. The Ontario Ministry of Health announced that the current funding rate of $1,500 per licensed long-term care bed per year will be maintained for 2026-2027 and ongoing, but funding for certain unoccupied ward beds will be removed, potentially reducing capitation fees by up to $2 million in 2026. The Board declared a dividend of CAD$0.02 per share, payable July 9, 2026.